Targeting α6GABAA receptors as a novel therapy for schizophrenia: A proof-of-concept preclinical study using various animal models

Lee M.T.Mouri A.Kubota H.Lee H.-J.Chang M.-H.Wu C.-Y.Knutson D.E.Mihovilovic M.Cook J.Sieghart W.Nabeshima T.LIH-CHU CHIOU2022-10-192022-10-1920227533322https://www.scopus.com/inward/record.uri?eid=2-s2.0-85129474709&doi=10.1016%2fj.biopha.2022.113022&partnerID=40&md5=bda93cce8df55b9b89342bb0984a3beahttps://scholars.lib.ntu.edu.tw/handle/123456789/623888Targeting α6GABAA receptors as a novel therapy for schizophrenia: A proof-of-concept preclinical study using various animal modelsjournal article10.1016/j.biopha.2022.113022354831952-s2.0-85129474709